Home›Stock Screener›Cipla›P/B Ratio

Cipla P/B Ratio

Current P/B Ratio
3.36
High Valuation
High - Premium to book value, growth expectations or asset-light model

Cipla (CIPLA) P/B ratio is 3.36 (High), book value per share ₹2130.86 vs Healthcare average P/B of -0.31 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Cipla stock price NSE.

Current Valuation Metrics

P/B Ratio 3.36
Current Price ₹1410.60
Book Value/Share ₹2130.86
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹34,520 Cr
Share Capital ₹162 Cr
Reserves & Surplus ₹34,270 Cr
Outstanding Shares 162,000,000
Book Value per Share ₹2130.86

Valuation Signal

Signal Overvalued
Historical Avg 0.81
Historical Range 0.66 - 0.92
Percentile 100.0%

Sector Context

Sector Average -0.31
Sector Median 0.57
Sector Rank #11 of 50
Sector Percentile 22.0%

CIPLA P/B Ratio — Valuation Insights & Book Value Analysis

Cipla price-to-book ratio interpretation, valuation status and historical context — current P/B 3.36 (High). Review Cipla price earnings to evaluate earnings-based valuation against sector peers.

  • Stock appears overvalued with PB of 3.36, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 316.9% above historical average
  • Trading at premium to sector average PB of -0.31

Cipla P/B Ratio Historical Trend

CIPLA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View CIPLA 52-week high low for the annual high/low range and current price position.

CIPLA Historical P/B Ratio — Book Value Per Share & Year-End Price

Cipla annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.66 ₹2130.86 ₹1410.60 ₹34,520 Low
2025 0.78 ₹1931.42 ₹1511.30 ₹31,289 Low
2024 0.92 ₹1654.44 ₹1529.00 ₹26,802 Low
2023 0.85 ₹1472.92 ₹1246.30 ₹23,714 Low
2022 0.82 ₹1311.61 ₹1075.95 ₹21,117 Low

CIPLA vs Healthcare Peers — P/B Ratio Comparison

Cipla P/B 3.36 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.

Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.22 ₹72 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low